
Aura Regenerative Center • Education. Transparency. Patient-centered care.

Please check all therapies received at Aura Regenerative Center:
| Clinical Area | Baseline Prior to Treatment | 1 Month After Treatment | 3 Months After Treatment | 6 Months After Treatment | 9 Months After Treatment |
|---|---|---|---|---|---|
| Head Control | |||||
| Trunk / Core Stability | |||||
| Sitting Balance | |||||
| Standing Ability | |||||
| Walking / Mobility | |||||
| Muscle Tone / Spasticity | |||||
| Fine Motor Function | |||||
| Hand Coordination | |||||
| Speech / Communication | |||||
| Eye Contact / Awareness | |||||
| Cognitive Engagement | |||||
| Emotional Regulation | |||||
| Feeding / Swallowing | |||||
| Sleep Regulation | |||||
| Energy / Endurance | |||||
| Seizure Control (if applicable) | |||||
| TOTAL (out of 80) | 0 / 80 | 0 / 80 | 0 / 80 | 0 / 80 | 0 / 80 |
Aura Regenerative Center believes that ongoing patient monitoring and functional outcome tracking are essential components of neurological regenerative therapy.
As part of our commitment to continuity of care, patients may be monitored through structured follow-up assessments at:
These follow-up evaluations are designed to document functional progression, neurological observations, developmental milestones, and overall quality of life changes reported by caregivers over time.
This document is intended solely for patient monitoring, observational tracking, and follow-up documentation purposes at Aura Regenerative Center. Clinical responses and outcomes vary between patients. Regenerative therapies including Mesenchymal Stem Cells, Exosomes, Dezawa MuseCells®️, MuseExosomes®️, and Neuropeptide Therapy are not guaranteed treatments or cures and do not replace ongoing medical care, rehabilitation therapies, or specialist management. Final treatment recommendations and protocols are determined exclusively through physician evaluation and medical discretion.